Back to Journals » Clinical Pharmacology: Advances and Applications

Clinical Pharmacology: Advances and Applications


Journal Articles:

- 150 records -

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2017, 9:133-145

Published Date: 8 November 2017

Antipsychotic prescription to identify delirium: results from two cohorts

Zimmerman KM, Paquin AM, Rudolph JL

Clinical Pharmacology: Advances and Applications 2017, 9:113-117

Published Date: 3 October 2017

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases

Dreesen E, Bossuyt P, Mulleman D, Gils A, Pascual-Salcedo D

Clinical Pharmacology: Advances and Applications 2017, 9:101-111

Published Date: 3 October 2017

Etanercept (Enbrel®) alternative storage at ambient temperature

Shannon E, Daffy J, Jones H, Paulson A, Vicik SM

Clinical Pharmacology: Advances and Applications 2017, 9:87-99

Published Date: 21 July 2017

NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment

North WG, Liu F, Lin LZ, Tian R, Akerman B

Clinical Pharmacology: Advances and Applications 2017, 9:79-86

Published Date: 17 July 2017

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D

Clinical Pharmacology: Advances and Applications 2017, 9:65-72

Published Date: 27 June 2017

An integrated epidemiological and neural net model of the warfarin effect in managed care patients

Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ

Clinical Pharmacology: Advances and Applications 2017, 9:55-64

Published Date: 18 May 2017

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F

Clinical Pharmacology: Advances and Applications 2017, 9:19-28

Published Date: 23 February 2017

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers

Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S

Clinical Pharmacology: Advances and Applications 2017, 9:9-17

Published Date: 11 January 2017

A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin

Goldwater R, Kramer WG, Hamilton DA, Lang E, Wang J, Madden DE, Lacouture PG, Ramaiya A, Carr DB

Clinical Pharmacology: Advances and Applications 2016, 8:203-212

Published Date: 15 December 2016

A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis

Thomas B, Mohamed M, Al Hail M, Awwad FA, Wahba RM, Hassan SB, Omar K, El Kassem W, Abdul Rouf P

Clinical Pharmacology: Advances and Applications 2016, 8:199-202

Published Date: 13 December 2016

Skin models for the testing of transdermal drugs

Abd E, Yousuf SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, Grice JE, Roberts MS

Clinical Pharmacology: Advances and Applications 2016, 8:163-176

Published Date: 19 October 2016

Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers

Parikh N, Kramer WG, Khurana V, Cognata Smith C, Vetticaden S

Clinical Pharmacology: Advances and Applications 2016, 8:155-162

Published Date: 12 October 2016

Exposure-response analysis to assess concentration–QTc relationship of CC-122

Li Y, Carayannopoulos LN,Thomas M, Palmisano M, Zhou S

Clinical Pharmacology: Advances and Applications 2016, 8:117-125

Published Date: 9 September 2016

Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation

Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P

Clinical Pharmacology: Advances and Applications 2016, 8:93-107

Published Date: 11 August 2016

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections

Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y

Clinical Pharmacology: Advances and Applications 2016, 8:15-18

Published Date: 30 March 2016

NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines

North WG, Liu F, Tian R, Abbasi H, Akerman B

Clinical Pharmacology: Advances and Applications 2015, 7:111-117

Published Date: 23 October 2015

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness

Kiuchi S, Hisatake S, Kawasaki M, Hirashima O, Kabuki T, Yamazaki J, Ikeda T

Clinical Pharmacology: Advances and Applications 2015, 7:97-102

Published Date: 8 October 2015

Pharmacokinetics and skin-tissue penetration of daptomycin in rats

Matsumoto K, Kitaoka M, Kuroda Y, Ikawa K, Morikawa N, Sasaki J, Iketani O, Iwata S, Horino T, Hori S, Kizu J

Clinical Pharmacology: Advances and Applications 2015, 7:79-82

Published Date: 21 May 2015

Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin

Tjandrawinata RR, Setiawati E, Putri RSI, Gunawan VA, Ong F, Susanto LW, Nofiarny D

Clinical Pharmacology: Advances and Applications 2015, 7:69-75

Published Date: 20 April 2015

Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers

Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, Sasano T, Goya M, Furukawa T, Isobe M, Hirao K

Clinical Pharmacology: Advances and Applications 2015, 7:29-36

Published Date: 16 February 2015

Parkinson's disease: carbidopa, nausea, and dyskinesia

Hinz M, Stein A, Cole T

Clinical Pharmacology: Advances and Applications 2014, 6:189-194

Published Date: 14 November 2014

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F

Clinical Pharmacology: Advances and Applications 2014, 6:179-187

Published Date: 13 November 2014

Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal

Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL

Clinical Pharmacology: Advances and Applications 2014, 6:171-177

Published Date: 31 October 2014

The Parkinson's disease death rate: carbidopa and vitamin B6

Hinz M, Stein A, Cole T

Clinical Pharmacology: Advances and Applications 2014, 6:161-169

Published Date: 21 October 2014

Melatonergic drugs in development

Carocci A, Catalano A, Sinicropi MS

Clinical Pharmacology: Advances and Applications 2014, 6:127-137

Published Date: 18 September 2014

Reducing medication errors in critical care: a multimodal approach

Kruer RM, Jarrell AS, Latif A

Clinical Pharmacology: Advances and Applications 2014, 6:117-126

Published Date: 1 September 2014

Effect of age and sex on warfarin dosing

Khoury G, Sheikh-Taha M

Clinical Pharmacology: Advances and Applications 2014, 6:103-106

Published Date: 12 July 2014

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes

Nakamura M, Sasai N, Hisatome I, Ichida K

Clinical Pharmacology: Advances and Applications 2014, 6:79-86

Published Date: 3 May 2014

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Chronic hepatitis C: future treatment

Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M

Clinical Pharmacology: Advances and Applications 2014, 6:1-17

Published Date: 8 January 2014

Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum

Decker BS, O’Neill KD, Chambers MA, Slaven JE, Yu Z, Jones DR, Moe SM

Clinical Pharmacology: Advances and Applications 2013, 5:193-199

Published Date: 10 December 2013

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response

Kreutz RP, Owens J, Jin Y, Nystrom P, Desta Z, Kreutz Y, Breall JA, Li L, Chiang CW, Kovacs RJ, Flockhart DA

Clinical Pharmacology: Advances and Applications 2013, 5:185-192

Published Date: 9 December 2013

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects

Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C

Clinical Pharmacology: Advances and Applications 2013, 5:177-184

Published Date: 6 December 2013

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model

Lozano R, Domeque N, Apesteguia AF

Clinical Pharmacology: Advances and Applications 2013, 5:153-159

Published Date: 27 September 2013

Impact of denosumab on bone mass in cancer patients

Brown-Glaberman U, Stopeck AT

Clinical Pharmacology: Advances and Applications 2013, 5:117-129

Published Date: 4 July 2013

Synthetic cathinone abuse

Capriola M

Clinical Pharmacology: Advances and Applications 2013, 5:109-115

Published Date: 2 July 2013

Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review

Brennan JL, Leung JG, Gagliardi JP, Rivelli SK, Muzyk AJ

Clinical Pharmacology: Advances and Applications 2013, 5:99-107

Published Date: 3 July 2013

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Upreti VV, Song Y, Wang J, Byon W, Boyd RA, Pursley JM, LaCreta F, Frost CE

Clinical Pharmacology: Advances and Applications 2013, 5:59-66

Published Date: 16 April 2013

Effect of statin therapy on vaspin levels in type 2 diabetic patients

Al-Azzam SI, Alzoubi KH, Abu Abeeleh J, Mhaidat NM, Abu-Abeeleh M

Clinical Pharmacology: Advances and Applications 2013, 5:33-38

Published Date: 20 February 2013

Arginine deprivation therapy for malignant melanoma

Yoon JK, Frankel AE, Feun LG, Ekmekcioglu S, Kim KB

Clinical Pharmacology: Advances and Applications 2013, 5:11-19

Published Date: 27 December 2012

Use of ipilimumab in the treatment of melanoma

Acharya UH, Jeter JM

Clinical Pharmacology: Advances and Applications 2013, 5:21-27

Published Date: 9 August 2013

Pazopanib for the treatment of soft-tissue sarcoma

Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranchère-Vince D, Blay JY, Ray-Coquard I

Clinical Pharmacology: Advances and Applications 2012, 4:65-70

Published Date: 26 October 2012

Sedation in the intensive care setting

Hughes CG, McGrane S, Pandharipande PP

Clinical Pharmacology: Advances and Applications 2012, 4:53-63

Published Date: 25 October 2012

Erratum

Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L

Clinical Pharmacology: Advances and Applications 2012, 4:51-52

Published Date: 13 September 2012

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L

Clinical Pharmacology: Advances and Applications 2012, 4:25-40

Published Date: 16 July 2012

Erratum

Barrese V, Miceli F, Soldovieri MV, Ambrosino P, Iannotti FA, Cilio MR, Taglialatela M

Clinical Pharmacology: Advances and Applications 2012, 4:23-24

Published Date: 26 March 2012

Smoking cessation

Kaur K, Juneja S, Kaushal S

Clinical Pharmacology: Advances and Applications 2012, 4:21-22

Published Date: 15 March 2012

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Kreutz RP, Nystrom P, Kreutz Y, Miao J, Desta Z, Breall JA, Li L, Chiang C, Kovacs R, Flockhart DA, Jin Y

Clinical Pharmacology: Advances and Applications 2012, 4:13-20

Published Date: 20 February 2012

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Gandy JJ, Meeding JP, Snyman JR, Janse van Rensburg CE

Clinical Pharmacology: Advances and Applications 2012, 4:7-11

Published Date: 17 February 2012

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Hashemi SN, Ghafarian Shirazi HR, Mohammadi A, Zadeh-Bagheri GH, Noorian KH, Malekzadeh M

Clinical Pharmacology: Advances and Applications 2012, 4:1-6

Published Date: 27 January 2012

Drug-resistant tuberculosis: emerging treatment options

Adhvaryu MR, Vakharia BC

Clinical Pharmacology: Advances and Applications 2011, 3:51-67

Published Date: 14 December 2011

A case of cephalothin-associated urolithiasis

Ivan WM Lim, Peter JO Stride, Robert L Horvath

Clinical Pharmacology: Advances and Applications 2011, 3:1-3

Published Date: 28 February 2011

Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine

Vincenzo Barrese, Francesco Miceli, Maria Virginia Soldovieri, et al

Clinical Pharmacology: Advances and Applications 2010, 2:225-236

Published Date: 7 December 2010

Editorial Foreword

Arthur E Frankel

Clinical Pharmacology: Advances and Applications 2010, 2:223-224

Published Date: 25 November 2010

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds

Ulrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al

Clinical Pharmacology: Advances and Applications 2010, 2:177-183

Published Date: 14 September 2010

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?

Rakesh K Sharma, Hanumanth K Reddy, Rohit K Sharma, et al

Clinical Pharmacology: Advances and Applications 2010, 2:155-162

Published Date: 6 September 2010

Testosterone replacement in male hypogonadism

Sanjay Kalra, Navneet Agrawal, Satish Kumar, et al

Clinical Pharmacology: Advances and Applications 2010, 2:149-153

Published Date: 10 September 2010

Rituximab in severe skin diseases: target, disease, and dose

Daniel D Bennett, Maro Ohanian, Christian T Cable

Clinical Pharmacology: Advances and Applications 2010, 2:135-141

Published Date: 7 July 2010

Managing insulin resistance: role of liraglutide

Sanjay Kalra, Bharti Kalra, Satish Kumar, et al

Clinical Pharmacology: Advances and Applications 2010, 2:131-134

Published Date: 24 June 2010

Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis

P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran

Clinical Pharmacology: Advances and Applications 2010, 2:123-130

Published Date: 17 June 2010

A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity

Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang, et al

Clinical Pharmacology: Advances and Applications 2010, 2:105-110

Published Date: 22 June 2010

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients

Biagio Di Iorio, Emanuele Cucciniello

Clinical Pharmacology: Advances and Applications 2010, 2:89-93

Published Date: 1 June 2010

Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer  treatment and/or higher doses?

Sayeeda Rahman, Aziz Al-Shafi Ismail, Shaiful Bhari Ismail, et al

Clinical Pharmacology: Advances and Applications 2010, 2:83-87

Published Date: 20 April 2010

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Guy Hans, Dominique Robert, Johanna Verhulst, et al

Clinical Pharmacology: Advances and Applications 2010, 2:65-70

Published Date: 30 March 2010

NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment

William G North, Guohong Gao, Amy Jensen, et al

Clinical Pharmacology: Advances and Applications 2010, 2:31-40

Published Date: 1 April 2010

Pharmacologic agents for smoking cessation: A clinical review

Dilip R Patel, Cynthia Feucht, Lesley Reid, et al

Clinical Pharmacology: Advances and Applications 2010, 2:17-29

Published Date: 7 April 2010

Nanoparticle-labeled stem cells: a novel therapeutic vehicle

Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry

Clinical Pharmacology: Advances and Applications 2010, 2:9-16

Published Date: 16 March 2010

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent

Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, et al

Clinical Pharmacology: Advances and Applications 2009, 1:1-6

Published Date: 7 September 2009